Estuary Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,326,849
| Closed | -$26.4M | – | 15 |
|
|
2025
Q1 | $26.4M | Sell |
3,326,849
-389,928
| -10% | -$3.09M | 6.4% | 8 |
|
|
2024
Q4 | $47.1M | Buy |
3,716,777
+972,997
| +35% | +$12.3M | 13.76% | 1 |
|
|
2024
Q3 | $38.2M | Buy |
2,743,780
+108,510
| +4% | +$1.51M | 10.25% | 2 |
|
|
2024
Q2 | $36.3M | Buy |
2,635,270
+1,024,133
| +64% | +$14.1M | 11.71% | 1 |
|
|
2024
Q1 | $26.6M | Buy |
1,611,137
+728,240
| +82% | +$12M | 10.81% | 2 |
|
|
2023
Q4 | $12.9M | Buy |
+882,897
| New | +$12.9M | 7.8% | 6 |
|